Deuruxolitinib and Alcohol/Food Interactions
There is 1 alcohol/food/lifestyle interaction with deuruxolitinib.
Deuruxolitinib Food/Lifestyle
Moderate Food Interaction
Consumer information for this interaction is not currently available.
MONITOR: Smoking during treatment with deuruxolitinib may increase the risk of major adverse cardiovascular events (MACE) and the risk of developing malignancies. In clinical studies of deuruxolitinib, individuals who were current or former smokers had an additional increased risk of overall malignancies. Also, deuruxolitinib may increase patients' risk of MACE, including myocardial infarction, stroke, and cardiovascular death.
MANAGEMENT: Caution is advised if deuruxolitinib is prescribed to current or past smokers. Patients should be informed about the symptoms of serious cardiovascular events and the steps to take if they occur. The manufacturer recommends discontinuing deuruxolitinib in patients that have experienced a myocardial infarction or stroke. Deuruxolitinib may be taken with or without food.
Switch to professional interaction data
Deuruxolitinib drug interactions
There are 336 drug interactions with deuruxolitinib.
Deuruxolitinib disease interactions
There are 8 disease interactions with deuruxolitinib which include:
- infections
- cardiovascular risk
- malignancy
- thrombosis
- cytopenias
- gastrointestinal perforation
- liver dysfunction
- renal dysfunction
Report options
More about deuruxolitinib
- deuruxolitinib consumer information
- Check interactions
- Compare alternatives
- Dosage information
- Drug class: multikinase inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.